BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32937197)

  • 1. Targeting glutamine metabolism as an effective means to promote allograft acceptance while inhibit tumor growth.
    Lee CF; Cheng CH; Hung HC; Chan KM; Lee WC
    Transpl Immunol; 2020 Dec; 63():101336. PubMed ID: 32937197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing Allograft Rejection by Targeting Immune Metabolism.
    Lee CF; Lo YC; Cheng CH; Furtmüller GJ; Oh B; Andrade-Oliveira V; Thomas AG; Bowman CE; Slusher BS; Wolfgang MJ; Brandacher G; Powell JD
    Cell Rep; 2015 Oct; 13(4):760-770. PubMed ID: 26489460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
    Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
    Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blimp-1 prolongs allograft survival without regimen via influencing T cell development in favor of regulatory T cells while suppressing Th1.
    Wang AYL; Loh CYY; Chen SJ; Kao HK; Lin CH; Chuang SH; Lee CM; Sytwu HK; Wei FC
    Mol Immunol; 2018 Jul; 99():53-65. PubMed ID: 29698799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor dendritic cell-derived exosomes promote allograft-targeting immune response.
    Liu Q; Rojas-Canales DM; Divito SJ; Shufesky WJ; Stolz DB; Erdos G; Sullivan ML; Gibson GA; Watkins SC; Larregina AT; Morelli AE
    J Clin Invest; 2016 Aug; 126(8):2805-20. PubMed ID: 27348586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicinal herbs Fructus corni and Semen cuscutae suppress allograft rejection via distinct immune mechanisms.
    Liu X; Zeng YQ; Liang YZ; Zou C; Liu H; Qiu F; Liang CL; Jin XW; Su ZR; Dai Z
    Oncotarget; 2016 Jun; 7(24):35680-35691. PubMed ID: 27256977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting pancreatic cancer metabolic dependencies through glutamine antagonism.
    Encarnación-Rosado J; Sohn ASW; Biancur DE; Lin EY; Osorio-Vasquez V; Rodrick T; González-Baerga D; Zhao E; Yokoyama Y; Simeone DM; Jones DR; Parker SJ; Wild R; Kimmelman AC
    Nat Cancer; 2024 Jan; 5(1):85-99. PubMed ID: 37814010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis.
    Manivannan S; Baxter VK; Schultz KL; Slusher BS; Griffin DE
    J Virol; 2016 Oct; 90(20):9251-62. PubMed ID: 27489275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone prevents acute and chronic cardiac allograft rejection.
    Kosuge H; Haraguchi G; Koga N; Maejima Y; Suzuki J; Isobe M
    Circulation; 2006 Jun; 113(22):2613-22. PubMed ID: 16735678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine.
    Wang SZ; Poore B; Alt J; Price A; Allen SJ; Hanaford AR; Kaur H; Orr BA; Slusher BS; Eberhart CG; Raabe EH; Rubens JA
    Clin Cancer Res; 2019 Oct; 25(19):5925-5936. PubMed ID: 31300448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Effects of Glutamine Inhibition Strategies on Antitumor CD8 T Cells.
    Madden MZ; Ye X; Chi C; Fisher EL; Wolf MM; Needle GA; Bader JE; Patterson AR; Reinfeld BI; Landis MD; Hathaway ES; Muka JE; O'Neil RT; Karijolich J; Philip M; Rathmell JC
    J Immunol; 2023 Aug; 211(4):563-575. PubMed ID: 37341499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta (TGFβ) plays a crucial role in prolonging allograft survival in an allodepletion ("pruning") skin transplant model.
    Watson D; Zhang GY; Hu M; Wang YM; Fletcher J; Sartor M; Alexander SI
    Transpl Immunol; 2014 May; 30(4):168-77. PubMed ID: 24746800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD45RB and donor-specific spleen cells transfusion inhibition allograft skin rejection mediated by memory T cells.
    Jian YQ; Ye J; Qi H; Deng CY; Deng SP; Li FR
    Immunol Cell Biol; 2017 Feb; 95(2):189-197. PubMed ID: 27616751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts.
    Thornley TB; Brehm MA; Markees TG; Shultz LD; Mordes JP; Welsh RM; Rossini AA; Greiner DL
    J Immunol; 2006 Feb; 176(3):1561-70. PubMed ID: 16424185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ donor or graft pretreatment to prolong allograft survival: lessons learned in the murine model.
    Pollak R; Blanchard JM
    Transplantation; 2000 Jun; 69(11):2432-9. PubMed ID: 10868654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous allograft tolerance in B7-deficient mice independent of preexisting endogenous CD4+CD25+ regulatory T-cells.
    Grazia TJ; Plenter RJ; Doan AN; Kelly BP; Weber SM; Kurche JS; Cushing SO; Gill RG; Pietra BA
    Transplantation; 2007 Jun; 83(11):1449-58. PubMed ID: 17565318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting glutamine metabolism exhibits anti-tumor effects in thyroid cancer.
    Zhang GQ; Xi C; Ju NT; Shen CT; Qiu ZL; Song HJ; Luo QY
    J Endocrinol Invest; 2024 Feb; ():. PubMed ID: 38386265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term cardiac allograft survival across an MHC mismatch after "pruning" of alloreactive CD4 T cells.
    Hu M; Watson D; Zhang GY; Graf N; Wang YM; Sartor M; Howden B; Fletcher J; Alexander SI
    J Immunol; 2008 May; 180(10):6593-603. PubMed ID: 18453578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.